Sleep Apnea Devices Market Set to Reach US$ 12.23 Billion by 2033 ~ 2025 Research Report
The "Sleep Apnea Devices Market Forecast Report by Types, Therapeutic Devices, Diagnostic Devices, End User, Country and ...
Future Market Insights2 天
Sleep Apnea Implants Industry to Reach USD 1,158.1 Million by 2033 at a 13.8% of CAGR
The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...
Rolling Out10 天
How a sleep mask for apnea reduces high blood pressure risk
Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
Future Market Insights12 天
Sleep Apnea Diagnostic Systems Industry to Nearly Double, Reaching USD 9.27 Billion by 2033 ...
The sleep apnea diagnostic systems market is expected to grow from US$ 4.81 billion in 2023 to US$ 9.27 billion by 2033, at a ...
Knowridge10 天
Innovative drug therapy can effectively treat sleep apnea
Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...
The best sleep tech from CES 2025 so far — from brain bands to singing smart rings
From sleep apnea-fighting mattresses to smart rings that play lullabies, the best sleep tech from Day 1 of CES 2025 ...
CNN1 个月
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...
Fox News26 天
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...